Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 300

1.

MicroRNA let-7d is a target of cannabinoid CB1 receptor and controls cannabinoid signaling.

Chiarlone A, Börner C, Martín-Gómez L, Jiménez-González A, García-Concejo A, García-Bermejo ML, Lorente M, Blázquez C, García-Taboada E, de Haro A, Martella E, Höllt V, Rodríguez R, Galve-Roperh I, Kraus J, Guzmán M.

Neuropharmacology. 2016 Sep;108:345-52. doi: 10.1016/j.neuropharm.2016.05.007. Epub 2016 May 11.

PMID:
27179908
2.

Tolerance to LSD and DOB induced shaking behaviour: differential adaptations of frontocortical 5-HT(2A) and glutamate receptor binding sites.

Buchborn T, Schröder H, Dieterich DC, Grecksch G, Höllt V.

Behav Brain Res. 2015 Mar 15;281:62-8. doi: 10.1016/j.bbr.2014.12.014. Epub 2014 Dec 13.

PMID:
25513973
3.

Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling.

Buchborn T, Schröder H, Höllt V, Grecksch G.

J Psychopharmacol. 2014 Jun;28(6):545-52. doi: 10.1177/0269881114531666. Epub 2014 Apr 30.

PMID:
24785760
4.

Dynamic aspects of cerebral hypoxic preconditioning measured in an in vitro model.

Brödemann R, Peters B, Höllt V, Becker A.

Neurosci Lett. 2014 Jan 13;558:175-9. doi: 10.1016/j.neulet.2013.10.069. Epub 2013 Nov 13.

PMID:
24240010
5.

μ opioid receptor agonist-selective regulation of interleukin-4 in T lymphocytes.

Börner C, Lanciotti S, Koch T, Höllt V, Kraus J.

J Neuroimmunol. 2013 Oct 15;263(1-2):35-42. doi: 10.1016/j.jneuroim.2013.07.012. Epub 2013 Jul 25.

PMID:
23965172
6.

Behavioral and neurochemical characterization of kratom (Mitragyna speciosa) extract.

Stolt AC, Schröder H, Neurath H, Grecksch G, Höllt V, Meyer MR, Maurer HH, Ziebolz N, Havemann-Reinecke U, Becker A.

Psychopharmacology (Berl). 2014 Jan;231(1):13-25. doi: 10.1007/s00213-013-3201-y. Epub 2013 Jul 12.

PMID:
23846544
7.

Cannabinoid-mediated diversity of antinociceptive efficacy of parecoxib in Wistar and Sprague Dawley rats in the chronic constriction injury model of neuropathic pain.

Becker A, Geisslinger G, Murín R, Grecksch G, Höllt V, Zimmer A, Schröder H.

Naunyn Schmiedebergs Arch Pharmacol. 2013 May;386(5):369-82. doi: 10.1007/s00210-013-0839-2. Epub 2013 Feb 1.

PMID:
23371449
8.

Regulation of opioid and cannabinoid receptor genes in human neuroblastoma and T cells by the epigenetic modifiers trichostatin A and 5-aza-2'-deoxycytidine.

Börner C, Martella E, Höllt V, Kraus J.

Neuroimmunomodulation. 2012;19(3):180-6. doi: 10.1159/000331474. Epub 2012 Jan 18.

PMID:
22262103
9.

Mechanisms of the inhibition of nuclear factor-κB by morphine in neuronal cells.

Börner C, Höllt V, Kraus J.

Mol Pharmacol. 2012 Apr;81(4):587-97. doi: 10.1124/mol.111.076620. Epub 2012 Jan 18.

PMID:
22258905
10.

Analgesic tolerance to high-efficacy agonists but not to morphine is diminished in phosphorylation-deficient S375A μ-opioid receptor knock-in mice.

Grecksch G, Just S, Pierstorff C, Imhof AK, Glück L, Doll C, Lupp A, Becker A, Koch T, Stumm R, Höllt V, Schulz S.

J Neurosci. 2011 Sep 28;31(39):13890-6. doi: 10.1523/JNEUROSCI.2304-11.2011.

11.

Agonist-selective patterns of µ-opioid receptor phosphorylation revealed by phosphosite-specific antibodies.

Doll C, Konietzko J, Pöll F, Koch T, Höllt V, Schulz S.

Br J Pharmacol. 2011 Sep;164(2):298-307. doi: 10.1111/j.1476-5381.2011.01382.x.

12.

Parecoxib and its metabolite valdecoxib directly interact with cannabinoid binding sites in CB1-expressing HEK 293 cells and rat brain tissue.

Schröder H, Höllt V, Becker A.

Neurochem Int. 2011 Jan;58(1):9-13. doi: 10.1016/j.neuint.2010.10.018. Epub 2010 Nov 10.

PMID:
21073910
13.

Epigenetic mechanisms involved in the induction of the mu opioid receptor gene in Jurkat T cells in response to interleukin-4.

Kraus J, Lehmann L, Börner C, Höllt V.

Mol Immunol. 2010 Nov-Dec;48(1-3):257-63. doi: 10.1016/j.molimm.2010.08.002. Epub 2010 Sep 9.

PMID:
20828825
14.

Role of phospholipase D2/phosphatidic acid signal transduction in micro- and delta-opioid receptor endocytosis.

Yang L, Seifert A, Wu D, Wang X, Rankovic V, Schröder H, Brandenburg LO, Höllt V, Koch T.

Mol Pharmacol. 2010 Jul;78(1):105-13. doi: 10.1124/mol.109.063107. Epub 2010 Mar 30.

PMID:
20354103
15.

Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling.

Börner C, Smida M, Höllt V, Schraven B, Kraus J.

J Biol Chem. 2009 Dec 18;284(51):35450-60. doi: 10.1074/jbc.M109.006338.

16.

ADP-ribosylation factor 6 regulates mu-opioid receptor trafficking and signaling via activation of phospholipase D2.

Rankovic M, Jacob L, Rankovic V, Brandenburg LO, Schröder H, Höllt V, Koch T.

Cell Signal. 2009 Dec;21(12):1784-93. doi: 10.1016/j.cellsig.2009.07.014. Epub 2009 Aug 7.

PMID:
19666113
17.

Transient prenatal vitamin D deficiency is associated with changes of synaptic plasticity in the dentate gyrus in adult rats.

Grecksch G, Rüthrich H, Höllt V, Becker A.

Psychoneuroendocrinology. 2009 Dec;34 Suppl 1:S258-64. doi: 10.1016/j.psyneuen.2009.07.004.

PMID:
19647946
18.

Differential regulation of CXCL12 and PACAP mRNA expression after focal and global ischemia.

Riek-Burchardt M, Kolodziej A, Henrich-Noack P, Reymann KG, Höllt V, Stumm R.

Neuropharmacology. 2010 Jan;58(1):199-207. doi: 10.1016/j.neuropharm.2009.07.032. Epub 2009 Jul 30.

PMID:
19647005
19.

Mechanisms of opioid-mediated inhibition of human T cell receptor signaling.

Börner C, Warnick B, Smida M, Hartig R, Lindquist JA, Schraven B, Höllt V, Kraus J.

J Immunol. 2009 Jul 15;183(2):882-9. doi: 10.4049/jimmunol.0802763. Epub 2009 Jun 26.

20.

mu-opioid receptor-stimulated synthesis of reactive oxygen species is mediated via phospholipase D2.

Koch T, Seifert A, Wu DF, Rankovic M, Kraus J, Börner C, Brandenburg LO, Schröder H, Höllt V.

J Neurochem. 2009 Aug;110(4):1288-96. doi: 10.1111/j.1471-4159.2009.06217.x. Epub 2009 Jun 10.

21.

Ampullosporin A, a peptaibol from Sepedonium ampullosporum HKI-0053 with neuroleptic-like activity.

Berek I, Becker A, Schröder H, Härtl A, Höllt V, Grecksch G.

Behav Brain Res. 2009 Nov 5;203(2):232-9. doi: 10.1016/j.bbr.2009.05.012. Epub 2009 May 18.

PMID:
19450625
22.

Allosteric modulation of metabotropic glutamate receptor 5 affects phosphorylation, internalization, and desensitization of the micro-opioid receptor.

Schröder H, Wu DF, Seifert A, Rankovic M, Schulz S, Höllt V, Koch T.

Neuropharmacology. 2009 Mar;56(4):768-78. doi: 10.1016/j.neuropharm.2008.12.010.

PMID:
19162047
23.

Membrane glycoprotein M6A promotes mu-opioid receptor endocytosis and facilitates receptor sorting into the recycling pathway.

Liang YJ, Wu DF, Stumm R, Höllt V, Koch T.

Cell Res. 2008 Jul;18(7):768-79. doi: 10.1038/cr.2008.71.

24.

Emotional and learning behaviour in mice overexpressing heat shock protein 70.

Ammon-Treiber S, Grecksch G, Angelidis C, Vezyraki P, Höllt V, Becker A.

Neurobiol Learn Mem. 2008 Sep;90(2):358-64. doi: 10.1016/j.nlm.2008.04.006. Epub 2008 Jun 3.

PMID:
18511309
25.

T-cell receptor/CD28-mediated activation of human T lymphocytes induces expression of functional mu-opioid receptors.

Börner C, Kraus J, Bedini A, Schraven B, Höllt V.

Mol Pharmacol. 2008 Aug;74(2):496-504. doi: 10.1124/mol.108.046029. Epub 2008 May 7.

PMID:
18463202
26.

Tonic activation of CXC chemokine receptor 4 in immature granule cells supports neurogenesis in the adult dentate gyrus.

Kolodziej A, Schulz S, Guyon A, Wu DF, Pfeiffer M, Odemis V, Höllt V, Stumm R.

J Neurosci. 2008 Apr 23;28(17):4488-500. doi: 10.1523/JNEUROSCI.4721-07.2008.

27.

Endogenous opioids inhibit ischemia-induced generation of immature hippocampal neurons via the mu-opioid receptor.

Kolodziej A, Stumm R, Becker A, Höllt V.

Eur J Neurosci. 2008 Mar;27(6):1311-9. doi: 10.1111/j.1460-9568.2008.06111.x. Epub 2008 Mar 7.

PMID:
18331339
28.

Activation of human T cells induces upregulation of cannabinoid receptor type 1 transcription.

Börner C, Höllt V, Kraus J.

Neuroimmunomodulation. 2007;14(6):281-6. doi: 10.1159/000117809. Epub 2008 Feb 21.

PMID:
18287809
29.

Analysis of promoter regions regulating basal and interleukin-4-inducible expression of the human CB1 receptor gene in T lymphocytes.

Börner C, Bedini A, Höllt V, Kraus J.

Mol Pharmacol. 2008 Mar;73(3):1013-9. Epub 2007 Dec 21.

PMID:
18156315
30.

Role of receptor internalization in opioid tolerance and dependence.

Koch T, Höllt V.

Pharmacol Ther. 2008 Feb;117(2):199-206. Epub 2007 Nov 17. Review.

PMID:
18076994
31.

Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors.

Wu DF, Yang LQ, Goschke A, Stumm R, Brandenburg LO, Liang YJ, Höllt V, Koch T.

J Neurochem. 2008 Feb;104(4):1132-43. Epub 2007 Nov 6.

32.

Differential effects of mu-opioid receptor agonists in a hippocampal hypoxia/hypoglycemia model.

Ammon-Treiber S, Stolze D, Höllt V.

Brain Res. 2007 Dec 5;1183:60-5. Epub 2007 Sep 14.

PMID:
17936735
33.
34.

Comparative analysis of mu-opioid receptor expression in immune and neuronal cells.

Börner C, Stumm R, Höllt V, Kraus J.

J Neuroimmunol. 2007 Aug;188(1-2):56-63. Epub 2007 Jun 11.

PMID:
17561272
35.

Membrane glycoprotein M6a interacts with the micro-opioid receptor and facilitates receptor endocytosis and recycling.

Wu DF, Koch T, Liang YJ, Stumm R, Schulz S, Schröder H, Höllt V.

J Biol Chem. 2007 Jul 27;282(30):22239-47. Epub 2007 Jun 4.

36.

Patterns of SDF-1alpha and SDF-1gamma mRNAs, migration pathways, and phenotypes of CXCR4-expressing neurons in the developing rat telencephalon.

Stumm R, Kolodziej A, Schulz S, Kohtz JD, Höllt V.

J Comp Neurol. 2007 May 20;502(3):382-99.

PMID:
17366607
38.

Pentylenetetrazol-kindling in mice overexpressing heat shock protein 70.

Ammon-Treiber S, Grecksch G, Angelidis C, Vezyraki P, Höllt V, Becker A.

Naunyn Schmiedebergs Arch Pharmacol. 2007 Apr;375(2):115-21. Epub 2007 Feb 28.

PMID:
17333130
39.

Immunofluorescent identification of neuropeptide B-containing nerve fibers and terminals in the rat hypothalamus.

Schulz S, Stumm R, Höllt V.

Neurosci Lett. 2007 Jan 3;411(1):67-71. Epub 2006 Oct 25.

PMID:
17067739
40.

Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids.

Börner C, Höllt V, Sebald W, Kraus J.

J Leukoc Biol. 2007 Jan;81(1):336-43. Epub 2006 Oct 13.

PMID:
17041005
41.

Interaction of the mu-opioid receptor with synaptophysin influences receptor trafficking and signaling.

Liang YJ, Wu DF, Yang LQ, Höllt V, Koch T.

Mol Pharmacol. 2007 Jan;71(1):123-31. Epub 2006 Sep 27.

PMID:
17005904
42.

Interferon-gamma down-regulates transcription of the mu-opioid receptor gene in neuronal and immune cells.

Kraus J, Börner C, Lendeckel U, Höllt V.

J Neuroimmunol. 2006 Dec;181(1-2):13-8. Epub 2006 Aug 17.

PMID:
16914208
43.

Development of tolerance and sensitization to different opioid agonists in rats.

Grecksch G, Bartzsch K, Widera A, Becker A, Höllt V, Koch T.

Psychopharmacology (Berl). 2006 Jun;186(2):177-84. Epub 2006 Mar 30.

PMID:
16572262
44.

Role of phospholipase D2 in the agonist-induced and constitutive endocytosis of G-protein coupled receptors.

Koch T, Wu DF, Yang LQ, Brandenburg LO, Höllt V.

J Neurochem. 2006 Apr;97(2):365-72. Epub 2006 Mar 15.

45.

Cannabinoid receptor type 2 agonists induce transcription of the mu-opioid receptor gene in Jurkat T cells.

Börner C, Höllt V, Kraus J.

Mol Pharmacol. 2006 Apr;69(4):1486-91. Epub 2006 Jan 24.

PMID:
16434616
46.

Pharmacogenetics of opioid receptors and addiction.

Mayer P, Höllt V.

Pharmacogenet Genomics. 2006 Jan;16(1):1-7. Review.

PMID:
16344716
47.
48.

Effects of opioid antagonists and morphine in a hippocampal hypoxia/hypoglycemia model.

Ammon-Treiber S, Stolze D, Schröder H, Loh H, Höllt V.

Neuropharmacology. 2005 Dec;49(8):1160-9. Epub 2005 Aug 11.

PMID:
16098996
49.

Delta-opioid receptor-immunoreactive neurons in the rat cranial sensory ganglia.

Ichikawa H, Schulz S, Höllt V, Sugimoto T.

Brain Res. 2005 May 10;1043(1-2):225-30.

PMID:
15862537
50.

Morphine-induced changes of gene expression in the brain.

Ammon-Treiber S, Höllt V.

Addict Biol. 2005 Mar;10(1):81-9. Review.

PMID:
15849022

Supplemental Content

Support Center